Status | Study |
Recruiting |
Study Name: A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension Condition: Pediatric Hypertension Date: 2016-06-01 Interventions: Drug: TAK-536 2.5 mg TAK-536 2 |
Completed |
Study Name: A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension Condition: Pediatric Hypertension Date: 2015-05-19 Interventions: Drug: Azilsartan Azilsartan tablets Other Name: TAK- |
Recruiting |
Study Name: An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension Condition: Hypertension Date: 2014-09-08 Interventions: Drug: Azilsartan Medoxomil Oth |
Completed |
Study Name: Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD Condition: Pediatric Hypertension With or Without CKD Date: 2012-06-06 Interventions: Drug: VAL489 Valsartan 3mg/kg |
Completed |
Study Name: Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age Condition: Hypertension Date: 2010-06-23 Interventions: Drug: Aliskiren (6.25/12.5/25 mg) |
Completed |
Study Name: An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age Condition: Hypertension Date: 2010-06-23 Interventions: Drug: Aliskiren |
Withdrawn |
Study Name: A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension Condition: Hypertension Date: 2007-09-10 Interventions: Drug: Cardene® I.V. 5 |
Completed |
Study Name: Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects Condition: Hypertension Date: 2005-11-17 Interventions: Drug: metoprolol succinate |
Completed |
Study Name: 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects Condition: Hypertension Date: 2005-11-17 Interventions: Drug: metoprolol succinate |
Completed |
Study Name: Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age Condition: Pediatric Hypertension Date: 2005-10-25 Interventions: Drug: candsartan cilexetil |